http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2341197-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10efc646a4dd605c2f09c493718f5b81
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B10-00
filingDate 2007-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2008-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c81580a9dbb15c7dca191ad646bbae0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59c37b09531577f2830ff4f1f1a64073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1741f5a2f8b0387c375cf0a4611ebf6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fb33fde20f500249abdf8e6a83b3fea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_adf2883bd033cde8db136edaa4db83ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0175ed2e4199d7d5af22a66e46edf057
publicationDate 2008-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2341197-C1
titleOfInvention Method of predicting of life expectancy of patients with local cancer of prostate
abstract FIELD: medicine. n SUBSTANCE: define risk factors from the anamnesis of a life and clinico-laboratory indicators: the age, degree of differentiation of a tumour, level of Testosteron-Depotum and prostates-specific antigen in blood serum (PSA), carry on prediction depending on their values, thus in addition define time from the development of hormone-resistance beginning, estimate level of painful sensations and the general condition of the patient on scale ECOG, define degree of disturbance of an emiction on international IPSS scale, establish gradation and numerical value of risk factors then define life expectancy of the patient in months under the formula: Y=-9.17+0.47•X 1 +1.94•X 2 -0.698•X 3 +0.01•X 4   2 +0.07•X 3   2 -1.66•X 5   2 +1.86•X 6   2 -0.0003•X 7   2 +0.01•X 8   2 , where: Y - life expectancy of the patient in months; X 1, 2...8 - gradation and numerical value of risk factors, and X 1 - age, years; X 2 - tumour differentiation: G 0 - low-grade tumour =0, G 1 differentiated tumour =1, G 2 - moderate-grade tumour =2, G 3 - a low-grade tumour =3, G 4 - an undifferentiated tumour =4; X 3 - Testosteron-Depotum level in ng/ml; X 4 - time from the beginning of hormone-resistance development in months; X 5 - level of painful sensations of the patient: absence of pain =0, mild pain =1, moderate pain d-2, strong pain =3, intolerable pain =4; X 6 - general condition of the patient on ECOG scale: activity of the patient is unlimited =0, restriction by kinds of activity of demanding efforts =1, walking and capable itself to serve, but incapable to perform any work =2, is limited capable for Self-Care =3, completely incapable of any activity =4; X 7 - level of the PSA in ng/ml; X 8 - degree of disturbance of an emiction at patients on international scale IPSS (from 0 to 36 points). n EFFECT: provides possibility of the prediction of life expectancy of patients in months. n 1 tbl, 2 ex
priorityDate 2007-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID48445
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP07288
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19147
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO60109
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID56318
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1209582
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP20646
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCB3EWC6
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21948
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6013
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID55
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID887988
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP14924
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00634
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554262
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81800
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ05700
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP34724
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID292872
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3818
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID719444
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP15309
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP33619
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA6H730
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID354
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8CE08
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID446918
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID45427207
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6DT45
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP30887
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ12546
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID841905
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6MWZ7
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25048
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8X176
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP83456
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ05205
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID16621
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP08091
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP86348

Total number of triples: 57.